News About: Pharm. Industry
KGC Sang-A to introduce influenza vaccine FluMist
Korea Green Cross Sang-A Pharm said it would distribute in Korea FluMist (influenza virus vaccine from next year, internasal), which was approved by the U.S. Food and Drug Administration as the first influenza vaccine...
KPMA vows to foster fair trade competition
The Korea Pharmaceutical Manufacturers Association said it would closely monitor all promotional assistance programs of pharmaceutical firms associated with the oncoming symposia at home and abroad, as part of its eff...
Additional designation of dextromethrophan into psychotropic substance raising concerns
Following the government's move to designate dextromethrophan as one of psychotropic substances from this October, a number of domestic pharmaceutical firms are now bracing for measures to boost their sales of cold re...
Hanmi Pharm's cefixime won COS
Hanmi Pharm said that it has acquired from the European Pharmacopoeia Commission the certification of suitability (COS) on cefixime, antibiotic bulk material, for the third time following ceftriaxone and cefotaxime, a...
Daewoong Pharm moving swiftly to extend its presence in domestic combined antidiabetic market
Reportedly, Daewoong Pharm has recently established its strategic alliance with Merck Korea for co-marketing of Glucovance, a novel oral glucose-lowering agent.
An official at Daewoong Pharm noted that unlike pr...
Brisk sale on injectable devices is seen
Following a tougher pharmaceutical inspection of the Korea Food and Drug Administration on KGMP-accredited firms every year, pharmaceutical equipment makers project that a number of pharmaceutical firms may replace th...
Health insurance allowance possible for Arimidex as second-line treatment for early breast cancer
AstraZeneca Korea said that Arimidex (anastrozole), a typical three-generation adjuvant for the treatment of postmenopausal women with hormone receptor-positive early breast cancer, may be reimbursable following the r...
Pharmaceutical raw material exports declined in first half
Korea's pharmaceutical bulk exports posted minus growth in the first half of this year and the trend may not turn around this year without improvements in business conditions, which has been marred by state's tougher ...
Notice to our readers
Due to Ch'usok, the Korean (version of) Thanksgiving Day English Yakup Daily will not publish September 10(Wednesday).
We resume publication on September 15(Monday), 2003.
- management-
Pharmaceutical firms bracing for administrative suit against price cut
As the Ministry of Health and Welfare will reduce health insurance prices of corresponding items from this Octobers 1st under the current actually transacted minimum price system, the majority of pharmaceutical firms ...
